Handmade quality · Free shipping over $75 · Explore the atelier

BMS-564929 0364 a significant and rapid reduction

SKU: 20873093147

4.8
USD125.00 USD174.00

Pay in 4 interest-free payments of $31.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

a significant and rapid reduction in leukemia burden was observed

3-thiazol-2-yl)carbamoyl](3

FGFR inhibitor AZD4547 binds to and inhibits FGFR

regulate the expression of apoptotic proteins Bcl-2

is a AMPA receptor agonist potentially for the treatment of major depression and anxiety

BMS-564929 0364 a significant and rapid reductionBMS 564929 is a highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator. BMS 564929 is a subnanomolar AR agonist in vitro, is highly selective for the AR vs. other steroid hormone receptors, and exhibits no significant interactions with SHBG or aromatase. Dose response studies in castrated male rats show that BMS 564929 is substantially more potent than testosterone (T) in stimulating the growth of the levator ani

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products